A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in <scp>Japanese</scp> patients with generalized anxiety disorder

Authors

Koichiro Watanabe (ORCID: https://orcid.org/0000-0002-0736-7070)
Tempei Otsubo (ORCID: https://orcid.org/0000-0002-0321-1714)
Shingo Higa (ORCID: https://orcid.org/0000-0002-9430-7809)
Kristina Marschall
Toshiaki Kikuchi (ORCID: https://orcid.org/0000-0001-7428-1245)
Keisuke Nomoto (ORCID: https://orcid.org/0000-0002-7469-2922)
Bin Sun
Takeshi Inoue (ORCID: https://orcid.org/0000-0002-4381-8000)
Yuko Asami
Ataru Inagaki

Institutions

Aoyama Gakuin University (JP)
Tokyo Medical University (JP)
Kyorin University (JP)
Keio University (JP)
Meda (Germany) (DE)
Hanazono Hospital (JP)
Tokyo Women's Medical University Adachi Medical Center (JP)
Tokyo Women's Medical University (JP)
Tris Pharma (United States) (US)

Publication Details

Journal: Psychiatry and Clinical Neurosciences
Published: 2025-10-22
DOI: https://doi.org/10.1111/pcn.13907
Citations: 3
Primary Topic: Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Type: article
Field-Weighted Citation Impact: 6.35

Funders

Eli Lilly and Company
Eisai
Meiji Seika Pharma
Shionogi
Otsuka Pharmaceutical
Teijin Pharma
Mitsubishi Tanabe Pharma Corporation
H. Lundbeck A/S
Daiichi Sankyo Europe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder

Koichiro Watanabe, Tempei Otsubo, Shingo Higa, Kristina Marschall et al.

Oct 22, 2025

3 citations

Psychiatry and Clinical Neurosciences

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

6.35

article

A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder

Koichiro Watanabe, Tempei Otsubo, Shingo Higa, Kristina Marschall, Toshiaki Kikuchi, Keisuke Nomoto, Bin Sun, Takeshi Inoue, Yuko Asami, Ataru Inagaki

October 22, 2025article en

3 citations

Abstract

No abstract available for this paper.

Psychiatry and Clinical NeurosciencesVol. 79(12)

Aoyama Gakuin University (JP), Tokyo Medical University (JP), Kyorin University (JP), Keio University (JP), Meda (Germany) (DE), Hanazono Hospital (JP), Tokyo Women's Medical University Adachi Medical Center (JP), Tokyo Women's Medical University (JP), Tris Pharma (United States) (US)

Eli Lilly and Company, Eisai, Meiji Seika Pharma, Shionogi, Otsuka Pharmaceutical, Teijin Pharma, Mitsubishi Tanabe Pharma Corporation, H. Lundbeck A/S, Daiichi Sankyo Europe

Openalex Percentile: Top 3%

Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes

6.35

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A randomized, double‐blinded, placebo‐controlled study to evaluate the efficacy and safety of venlafaxine extended release in <scp>Japanese</scp> patients with generalized anxiety disorder — Koichiro Watanabe, Tempei Otsubo, et al. · Psychiatry and Clinical Neurosciences (2025) | TGRS Research Map | TGRS